...
首页> 外文期刊>AAPS PharmSciTech >Investigations on the Physical Structure and the Mechanism of Drug Release from an Enteric Matrix Microspheres with a Near-Zero-Order Release Kinetics Using SEM and Quantitative FTIR
【24h】

Investigations on the Physical Structure and the Mechanism of Drug Release from an Enteric Matrix Microspheres with a Near-Zero-Order Release Kinetics Using SEM and Quantitative FTIR

机译:扫描电镜和定量红外光谱法研究具有零级释放动力学的肠溶基质微球的物理结构和释药机理

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objectives of this study were to evaluate the physical structure and the release mechanisms of theophylline microspheres made of Eudragit S 100 polymer as an enteric polymer, combined with a nonerodible polymer, Eudragit RL 100. In the preparation process, polymer combinations (1:1) were dissolved in an organic solvent mixture composed of acetone and methanol at a specific ratio containing a theoretical drug loading of approximately 15%. Two microsphere formulations (LS1 and LS2) were prepared at two different total polymer concentrations (10% in LS1 and 12.7% in LS2). Dissolution studies were carried out using US Pharmacopeia Dissolution Apparatus II in an acidic medium for 8 h and in an acidic medium (2 h) followed by a slightly basic-buffered medium for 10 h. Both LS1 and LS2 microsphere formulations produced particles that were spherical in shape and had very narrow size distributions with one size fraction comprising 70–80% of the yield. Scanning electron microscopy and quantitative Fourier transform infrared were used for microsphere physical structure evaluation. Except for the absence of drug crystals, photomicrographs of both LS microspheres after dissolution in pH 1.2 and 7.2 buffer solutions were similar to those before dissolution. Dissolution results indicated the ability of LS microspheres to minimize drug release during the acid stage. However, in the slightly basic medium that followed the acidic stage, the drug release was sustained and controlled in its kinetics and data fitted to Peppas equation indicated a case II transport suggesting that the drug release is mainly through swelling/erosion mechanism.
机译:这项研究的目的是评估由Eudragit S 100聚合物制成的肠溶聚合物与不可腐蚀的聚合物Eudragit RL 100组合制成的茶碱微球的物理结构和释放机理。在制备过程中,聚合物组合物(1:1将其以特定比例溶解于由丙酮和甲醇组成的有机溶剂混合物中,其理论载药量约为15%。以两种不同的总聚合物浓度(LS1中为10%,LS2中为12.7%)制备了两种微球制剂(LS1和LS2)。使用US Pharmacopeia溶出度仪II在酸性介质中溶8小时,然后在酸性介质中溶2 h,然后在弱碱性缓冲液中溶10 h,进行溶出研究。 LS1和LS2微球配方均产生球形的颗粒,尺寸分布非常狭窄,其中一个尺寸分数占产量的70-80%。扫描电子显微镜和定量傅立叶变换红外用于微球物理结构评价。除了不存在药物晶体外,两个LS微球在pH 1.2和7.2缓冲溶液中溶解后的显微照片与溶解前相似。溶出度结果表明,LS微球具有在酸性阶段将药物释放降至最低的能力。然而,在酸性阶段之后的基本碱性介质中,药物的释放得以维持并控制其动力学,根据Peppas方程拟合的数据表明病例II转运,表明药物释放主要是通过溶胀/侵蚀机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号